|
Report Date : |
30.01.2013 |
IDENTIFICATION DETAILS
|
Name : |
bio actives japan corporation |
|
|
|
|
Registered Office : |
Tensho Otsu-Ekimae Bldg 9F 1-6-20 Minamiotsuka Toshimaku Tokyo
170-0005 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.08.2012 |
|
|
|
|
Date of Incorporation : |
September, 2006 |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Import and Wholesale of Natural Botanical Extracts |
|
|
|
|
No. of Employees : |
4 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
Japan |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
japan - ECONOMIC OVERVIEW
In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A tiny agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. Usually self-sufficient in rice, Japan imports about 60% of its food on a caloric basis. Japan maintains one of the world's largest fishing fleets and accounts for nearly 15% of the global catch. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2011 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2011. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan further into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake in March disrupted manufacturing. Electricity supplies remain tight because Japan has temporarily shut down almost all of its nuclear power plants after the Fukushima Daiichi nuclear reactors were crippled by the earthquake and resulting tsunami. Estimates of the direct costs of the damage - rebuilding homes, factories, and infrastructure - range from $235 billion to $310 billion, and GDP declined almost 0.5% in 2011. Prime Minister Yoshihiko NODA has proposed opening the agricultural and services sectors to greater foreign competition and boosting exports through membership in the US-led Trans-Pacific Partnership trade talks and by pursuing free-trade agreements with the EU and others, but debate continues on restructuring the economy and reining in Japan's huge government debt, which exceeds 200% of GDP. Persistent deflation, reliance on exports to drive growth, and an aging and shrinking population are other major long-term challenges for the economy.
|
Source : CIA |
BIO ACTIVES JAPAN CORPORATION
KK Bio Actives
Japan
Tensho Otsu-Ekimae
Bldg 9F, 1-60-20 Minamiotsuka Toshimaku Tokyo 170-0005, Japan
Tel:
03-5981-0601 Fax: 03-5981-0602
URL: http://www.bioactivesjapan.com/
E-Mail address: info@bioactivesjapan.com
Import, wholesale
of natural botanical extracts
Nil
Higashi-Ikebukuro;
India
FAIZAL MOHAMMED,
PRES (Indian resident)
S Mohammed Saril,
dir
Yen Amount: In million Yen, unless otherwise stated
FINANCES FAIR A/SALES Yen 2,359 M
PAYMENTS NO COMPLAINTS CAPITAL Yen
15 M
TREND UP WORTH Yen 173 M
STARTED 2006 EMPLOYES 4
IMPORTER AND
WHOLESALER SPECIALIZING IN NATURAL BOTANICAL EXTRACTS.
FINANCIAL
SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.
The subject company
was established as Japan marketing office by Bio Actives, India, for marketing
its products of natural botanical extracts as mainline. This is a trading firm for import and
wholesale of natural botanical extracts from group firms in India centrally,
and USA. Partially processes them into
products and exports. Clients are in the
areas of nutraceuticals, cosmetics, pharmaceutical, health food mfrs, other. Client networks are expanding each year.
The sales volume for
Aug/2012 fiscal term amounted to Yen 2,359 million, a 58% up from Yen 1,492
million in the previous term. Client’s
networks expanded, with acquiring one large account in health food mfrs. Demand for natural bio actives increased from
cosmetics, health food, pharmaceutical industries. OEM production rose. The recurring profit was posted at Yen 179
million and the net profit at Yen 158 million, respectively, compared with Yen
97 million recurring profit and Yen 49 million net losses, respectively, a year
ago.
For the current
term ending Aug 2013 the recurring profit is projected at Yen 185 million and
the net profit at Yen 165 million, respectively, on a 4% rise in turnover to
Yen 2,450 million. Demand continues
strong and steady for natural bio-actives.
Business is seen steadily expanding.
The financial
situation is considered FAIR and good for ORDINARY business engagements.
Date Registered: Sept 2006
Legal Status: Limited
Company (Kabushiki Kaisha)
Authorized: 300
shares
Issued:
300 shares
Sum: Yen
15 million
Major shareholders (%): Faizal Mohammed (89.7), S Mohammed
Saril (10.3)
No. of shareholders: 2
Nothing
detrimental is known as to the commercial morality of executives.
Activities: Imports and
wholesales natural botanical extracts, beauty products, bio-technology
products, enzyme (ferment), preparations, health products, natural cosmetic
actives, natural cosmetic colors & preservatives, specialty chemicals,
pharmaceutical intermediates, others (--100%).
Goods are imported from its headquarters in India and other contracted
facilities throughout India, and USA.
Clients: [Pharmaceutical
mfrs, wholesalers] Astra Nutraceuticals, other.
Exports to: Taiwan, Korea, Philippines,
India (10%), other
No.
of accounts: Unavailable
Domestic
areas of activities: Nationwide
Suppliers: [Mfrs] Imports
mainly from Olive Lifesciences (90%), Astra Nutraceuticals (Chennai, India)
(5%), other from Europe, USA , China, other.
Payment
record: Regular
Location: Business area in Tokyo. Office premises at the caption address are
leased and maintained satisfactorily.
Bank
References:
State Bank of India (Tokyo)
MUFG (Tanashi-Ekimae)
Relations: Money deposits & transfers
only
(In Million Yen)
|
Terms Ending: |
31/08/2013 |
31/08/2012 |
31/08/2011 |
31/08/2010 |
|
|
Annual
Sales |
|
2,450 |
2,359 |
1,492 |
606 |
|
Recur.
Profit |
|
185 |
179 |
97 |
14 |
|
Net
Profit |
|
165 |
158 |
49 |
15 |
|
Total
Assets |
|
|
642 |
778 |
270 |
|
Current
Assets |
|
|
604 |
777 |
269 |
|
Current
Liabs |
|
|
468 |
691 |
243 |
|
Net
Worth |
|
|
173 |
87 |
27 |
|
Capital,
Paid-Up |
|
|
15 |
15 |
10 |
|
Div.P.Share(¥) |
|
|
0.00 |
0.00 |
0.00 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
3.86 |
58.11 |
146.20 |
105.42 |
|
|
Current Ratio |
|
.. |
129.06 |
112.45 |
110.70 |
|
N.Worth Ratio |
.. |
26.95 |
11.18 |
10.00 |
|
|
R.Profit/Sales |
|
7.55 |
7.59 |
6.50 |
2.31 |
|
N.Profit/Sales |
6.73 |
6.70 |
3.28 |
2.48 |
|
|
Return On Equity |
.. |
91.33 |
56.32 |
55.56 |
|
Notes: Forecast
(or estimated) figures for the 31/08/2013 fiscal term.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.70 |
|
|
1 |
Rs.84.35 |
|
Euro |
1 |
Rs.72.21 |
INFORMATION DETAILS
|
Report
Prepared by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.